Also known as: Abiraterone Acetate
Abiraterone is indicated for:
Population group: men, only adults (18 years old or older)
Abiraterone is indicated with prednisone or prednisolone for:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: men, only adults (18 years old or older)
Abiraterone is indicated with prednisone or prednisolone for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Abiraterone is contraindicated in the following cases: